Redeye is encouraged by the news that Ortoma continues to be active in the Japanese market and leverage the existing agreement with Johnson & Johnson within OTS™ Hip with a Memorandum of Understanding for the OTS™ Knee. This follows that Ortoma has successfully met the high standards in the Japanese market for OTS™ Hip. The agreement covers both OTS™ Plan and Guide and aims to evaluate the market requirements in Japan and define an extended version. The MoU also includes a negotiation period for the distribution rights in Japan with exclusive rights while the evaluation and negotiation for the distribution rights for Japan.
LÄS MER